| Description |
1 online resource |
| Note |
Online resource; title from PDF title page (EBSCO, viewed January 31, 2019) |
| Contents |
Front Cover; Alzheimer's Disease Theranostics; Alzheimer's Disease Theranostics; Copyright; Dedication; Biography; Acknowledgements; Contents; 1 -- Introduction: Alzheimer's Disease Pathology and Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; BIOCHEMISTRY; THERANOSTICS; Antibodies; Natural Compounds; Resveratrol; Ginkgo Biloba; Drugs; Nanotechnology; CONCLUSION AND FUTURE PERSPECTIVES; REFERENCES; 2 -- Early Diagnosis of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; CURCUMIN; CREATIVE DRAWING TECHNIQUE; Imaging Techniques; Positron Emission Tomography Radiotracers; GENETICS |
|
BIOMARKERSBlood Biomarkers; Protein Biomarkers; MIRNA; GLUCOSE LEVELS; CONCLUSION; REFERENCES; 3 -- Antioxidants in Alzheimer's Therapy; ABSTRACT; KEYWORDS; INTRODUCTION; ANTIOXIDANTS; Plant Extracts; Withanolides; NEUROINFLAMMATION-TARGETED THERAPEUTICS; Antioxidant Enzymes; Limitations; MELATONIN; LIPOIC ACID; NANOTECHNOLOGY; CONCLUSION; REFERENCES; 4 -- Natural Products in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; FLAVONOIDS; Epigallocatechin-3-Gallate; RESVERATROL; SAIKOSAPONINS; CURCUMIN; CLICK CHEMISTRY; NANOTECHNOLOGY; CHITOSAN; CONCLUSION; REFERENCES |
|
5 -- Blood-Brain Barrier-Targeted Nanotechnological AdvancesABSTRACT; KEYWORDS; INTRODUCTION; PHYSIOLOGY; PATHOLOGY; BCSFB; THERAPEUTICS; Matrix Metalloproteinases; Nanoparticles; Gold nanoparticles; Liposomes; Magnetic nanoparticles; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 6 -- Gene Therapy: The Cornerstone in the Development of Alzheimer's Disease Therapeutics; ABSTRACT; KEYWORDS; INTRODUCTION; PRESENILIN; STEM CELLS; MICRORNA/CDK5R1; HEAT SHOCK PROTEIN; BECLIN; APOLIPOPROTEIN E; DRUG MECHANISM/GENE MODIFICATION; NEUROINFLAMMATION AND CYTOKINES; CONCLUSION; REFERENCES |
|
7 -- Viral Vector Therapeutics Against Alzheimer's DiseaseABSTRACT; KEYWORDS; INTRODUCTION; Viral Vector Therapeutics; Adeno-Associated Viral Vectors; mAbs; Tau; PROGRANULIN; NEPRILYSIN; GENE-BASED IMMUNOTHERAPEUTIC METHODS; CONCLUSION; REFERENCES; 8 -- Mitochondria-Targeted Nanoparticles: A Milestone or a Mirage in the Treatment of Alzheimer's Disease; ABSTRACT; KEYWORDS; INTRODUCTION; Nanoparticles; Flurbiprofen Nanoparticles; Nattokinase Nanoparticles; Intranasal Delivery; Triphenylphosphonium Functionalization; Cerium Oxide Nanoparticles; CONCLUSION; REFERENCES |
|
9 -- Nanoparticles: The Double-Edged SwordsABSTRACT; KEYWORDS; INTRODUCTION; Nanotechnology; Polymeric Materials; Carbon Nanotubes; Hydrogels; Tissue Engineering Scaffolds; Delivery Systems for Growth Factors; Delivery Systems for Chelators; DEMERITS OF BIOMATERIALS; CONCLUSIONS AND FUTURE PERSPECTIVES; REFERENCES; 10 -- Alzheimer Therapeutics: Pros and Cons; ABSTRACT; KEYWORDS; INTRODUCTION; Neuroinflammation and Cytokines; Demerits; Antioxidants; Shortcomings; DRUG MECHANISM/GENE MODIFICATION; Neprilysin; Limitations; Nanotechnology; Gold Nanoparticles; Liposomes; Magnetic Nanoparticles |
| Subject |
Alzheimer's disease.
|
|
Alzheimer Disease. (DNLM)D000544
|
|
Theranostic Nanomedicine. (DNLM)D000068936
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Alzheimer's disease. (OCoLC)fst00806532
|
| Other Form: |
Print version: Obulesu, Magisetty. Alzheimer's disease theranostics. London : Elsevier, 2019 0128164123 9780128164129 (OCoLC)1044835474 |
| ISBN |
9780128167397 (electronic book) |
|
0128167394 (electronic book) |
|
9780128164129 |
|
0128164123 |
|
